logo

Global Human Milk Oligosaccharides Market Size (2024 - 2029)

The Human Milk Oligosaccharides market is projected to experience significant growth due to increasing health awareness and the rising demand for infant formula. These complex sugars, crucial for immune system stimulation and gut health, are gaining traction in functional foods, beverages, and supplements. The market's expansion is driven by consumer concerns over health and wellness, as well as the development of synthetic HMOs for use in infant formulas and medical nutrition.

Home Market Analysis Food & Beverage Research Food Ingredients and Food Additives Research Functional Food Ingredients Research Prebiotic Ingredients Research Human Milk Oligosaccharides Research Human Milk Oligosaccharides Industry Market Size

Market Size of Global Human Milk Oligosaccharides Industry

Human Milk Oligosaccharides Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 196.28 Million
Market Size (2029) USD 503.87 Million
CAGR (2024 - 2029) 20.75 %
Fastest Growing Market Asia Pacific
Largest Market Asia-Pacific
Market Concentration High

Major Players

Human Milk Oligosaccharides Market Major Players

*Disclaimer: Major Players sorted in no particular order

Human Milk Oligosaccharides (HMO) Market Analysis

The Global Human Milk Oligosaccharides Market size is estimated at USD 196.28 million in 2024, and is expected to reach USD 503.87 million by 2029, growing at a CAGR of 20.75% during the forecast period (2024-2029).

Human Milk Oligosaccharides (HMOs) are complex sugars available in human milk. They are the 3rd largest solid component in breast milk after fat and lactose and have no nutritive function. HMOs are responsible for directly stimulating the immune system by promoting good gut bacteria, strengthening the gut barrier function, and blocking pathogens. Changing consumer lifestyles and their increasing concerns regarding health and wellness are some of the other prominent factors driving the demand for HMOs around the world. Human milk oligosaccharides in functional food and beverage products and food supplements can help the treatment of certain disorders and high-risk health conditions, which in turn is anticipated to boost the product demand. Human milk oligosaccharides constitute a significant source of sialic acid, which is an essential part of the plasma membrane of nerve cells. Over 150 structurally diverse HMOs are available in nature. Moreover, scientists have been trying to develop various structures of HMOs synthetically for use in the food industry-most, particularly infant formulas and medical nutrition. These synthetically produced HMOs are safe for consumption by infants (who cannot be breastfed), as well as children and adults.

Human milk oligosaccharides find application in infant formula, functional food and beverages, and food supplements. Increasing health awareness and the rising consumption of infant formula are likely to boost the growth of the HMO market over the forecast period. The consumption of HMOs has contributed significantly catering to the rising concerns regarding health and safety, which are likely to boost market growth over the forecast period. HM, and Os play a key role in the proper development of infants. They fight life-threatening infections and are also responsible for properly developing the brain and gut. 

Human Milk Oligosaccharides (HMO) Industry Segmentation

Human Milk Oligosaccharides (HMOs) as a functional ingredient extracted from human breast milk act as inflammatory and immune modulators. They act as nutrients for the neurological development of infants. The Human Milk Oligosaccharides Market is segmented into application and geography. By application, the market is segmented into infant formula, dietary supplements, and functional food and beverage. The geographical analysis of the market has also been included in the study. By geography, the market is further segmented into North America, Europe, Asia-Pacific, and Rest of the World. For each segment, the market sizing and forecasts have been done on the basis of value (in USD million).

Application
Infant Formula
Dietary Supplements
Functional Food and Beverage
Geography
North America
United States
Canada
Mexico
Rest of North America
Europe
Germany
Spain
United Kingdom
France
Rest of Europe
Asia Pacific
China
Japan
Australia
Rest of Asia-Pacific
Rest of the World
South America
Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Global Human Milk Oligosaccharides Market Size Summary

The human milk oligosaccharides (HMO) market is poised for significant growth, driven by increasing consumer awareness of health and wellness. HMOs, complex sugars found in human milk, play a crucial role in stimulating the immune system and promoting gut health by fostering beneficial bacteria and enhancing gut barrier functions. Their application in infant formulas, functional foods, and dietary supplements is expanding, as they are recognized for their potential health benefits, including supporting immunity and cognitive development. The market is further bolstered by advancements in synthetic HMO production, making them safe for consumption by infants, children, and adults. This growth is supported by ongoing research and regulatory approvals, such as those pursued by Inbiose for various HMOs, which are expected to enhance their availability and application in the food industry.

Regionally, the Asia-Pacific market is experiencing robust growth due to the rising demand for high-nutrition foods and the expansion of the dairy industry. The region's focus on nutritious and functional foods, coupled with technological advancements, is driving the adoption of HMOs, particularly in infant formulas. The competitive landscape is marked by significant investments in research and development by key players like Koninklijke DSM N.V., Chr. Hansen Holding A/S, and BASF SE, who are actively expanding their HMO portfolios and establishing distribution networks. Regulatory approvals in various countries, such as those obtained by FrieslandCampina and BASF, are facilitating the introduction of HMO-based products, further propelling market growth.

Explore More

Global Human Milk Oligosaccharides Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Drivers

    2. 1.2 Market Restraints

    3. 1.3 Porter's Five Forces Analysis

      1. 1.3.1 Threat of New Entrants

      2. 1.3.2 Bargaining Power of Consumers

      3. 1.3.3 Bargaining Power of Suppliers

      4. 1.3.4 Threat of Substitute Products

      5. 1.3.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Application

      1. 2.1.1 Infant Formula

      2. 2.1.2 Dietary Supplements

      3. 2.1.3 Functional Food and Beverage

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

        4. 2.2.1.4 Rest of North America

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 Spain

        3. 2.2.2.3 United Kingdom

        4. 2.2.2.4 France

        5. 2.2.2.5 Rest of Europe

      3. 2.2.3 Asia Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 Japan

        3. 2.2.3.3 Australia

        4. 2.2.3.4 Rest of Asia-Pacific

      4. 2.2.4 Rest of the World

        1. 2.2.4.1 South America

        2. 2.2.4.2 Middle East and Africa

Global Human Milk Oligosaccharides Market Size FAQs

The Global Human Milk Oligosaccharides Market size is expected to reach USD 196.28 million in 2024 and grow at a CAGR of 20.75% to reach USD 503.87 million by 2029.

In 2024, the Global Human Milk Oligosaccharides Market size is expected to reach USD 196.28 million.

Human Milk Oligosaccharides Market Report Snapshots

Human Milk Oligosaccharides Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)